Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Comment by N0taP00pon Sep 03, 2024 9:48pm
279 Views
Post# 36207314

RE:RE:New Proactive Video

RE:RE:New Proactive VideoIt feels like these petri dish type NRs are  generally stacked closer to PP phases in the hopes of attracting new buyers.  It's a guess...and probably what they need to do tactically anyway while waiting for BTD data.  It's great stuff but feels like years and years away from approval.  The Kool-Aid folks here can be useful and fact check this stacking of NRs, say back to 2021.  I think we all know what matters at this point. No more pushouts of the BTD schedule (for items within their span of control). And at least 250K raised to provide a month or two of  breathing room. Good luck to all.  Oh, I love my TLT shares. 
Tarbaby wrote: Have they actually studied Ruvidar for HSV treatment in small animals or only on cells infected with the virus in vitro?
Then from animals to humans is a big step.
More details are needed to convince investors. In other words...show it... dont just say it. I truly hope its all real both for us investors and the public good.


<< Previous
Bullboard Posts
Next >>